Discontinuing or Tapering Biologic or Targeted Synthetic Disease‐Modifying Anti‐Rheumatic Drugs in Psoriatic Arthritis: A Systematic Literature Review
Tapering of biologic therapy in PsA patients may be effective and safe in low disease activity states. Lack of standardization of tapering strategies warrants further studies. The knowledge gap lies in the lack of data from high-quality RCTs and biomarkers that predict success in tapering therapy for patients with PsA.
Authors
- Kichul Shin (ORCID: https://orcid.org/0000-0002-6749-7598)
- Min Yi Natalie Aw (ORCID: https://orcid.org/0000-0003-2881-2572)
- Warren Weng Seng Fong (ORCID: https://orcid.org/0000-0003-1891-1892)
- Ying Ying Leung (ORCID: https://orcid.org/0000-0001-8492-6342)
- Stanley Angkodjojo
Institutions
- Singapore General Hospital (SG)
- New Generation University College (ET)
- Duke-NUS Medical School (SG)
- Sengkang General Hospital (SG)
Publication Details
- Journal
- International Journal of Rheumatic Diseases
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1111/1756-185x.70498
- Primary Topic
- Spondyloarthritis Studies and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00